INFORECERCA: Butlletí Informatiu del Servei de Recerca de l'IMIM
Número: 364
18/07/2014
Projectes
Termini exhaurit
INNOVATIVE MEDICINES INITIATIVE
IMI is a partnership between the European Union and the European pharmaceutical industry, represented by the European Federation of Pharmaceutical Industries and Associations (EFPIA).
The goal of the Innovative Medicines Initiative 2 (IMI 2) is to develop next generation vaccines, medicines and treatments, such as new antibiotics. It will build on the successes and lessons learnt under IMI. Like IMI, it will bring together companies, universities, public laboratories, innovative small and medium-sized enterprises (SMEs), patient groups and regulators in collaborative projects that will pave the way for breakthrough vaccines, medicines and treatments to tackle Europe’s growing health challenges, and secure the future international competitiveness of Europe’s pharmaceutical industry.
 
Termini exhaurit
FONDATION LEDUCQ
Fondation Leducq is a French non-profit health research foundation, the mission of which is to improve human health through international efforts to combat cardiovascular disease.

The Transatlantic Networks of Excellence in Cardiovascular Research Program is designed to promote collaborative research involving centers in North America and Europe in the areas of cardiovascular and neurovascular disease. The principal aims of this program are to develop international cardiovascular and neurovascular research networks that benefit from a demonstrable collaborative advantage; to advance science in the areas of cardiovascular and neurovascular disease; to apply the knowledge gained through research to promote the development of technology and therapeutics to improve human health; and to support the career development of young investigators in cardiovascular and neurovascular disease.

Each network is built around a transatlantic research alliance involving two network coordinators.
 
Termini exhaurit
EUROPEAN FOUNDATION FOR THE STUDY OF DIABETES (EFSD)
The EFSD/Lilly European Diabetes Research Fund was created to promote increased European diabetes research and to increase public awareness and political understanding of the magnitude and burden of the disease.
The EFSD/Lilly Programme will accept applications within any area of basic or clinical diabetes research.
 
Altres
Termini exhaurit
ALEXANDER VON HUMBOLDT FOUNDATION
The Alexander von Humboldt Foundation’s Sofja Kovalevskaja Award is granted to young exceptionally promising researchers from abroad in recognition of outstanding academic achievements. The award is designed to enable them to embark on academic careers in Germany by establishing their own junior research groups at research institutions in Germany.
The programme is open to scientists and scholars from all countries and disciplines who completed their doctorates with distinction less than six years ago. The Alexander von Humboldt Foundation particularly welcomes applications from qualified, female junior researchers.
 
Borses de viatge
Termini exhaurit
FUNDACIÓ ACADÈMIA DE CIÈNCIES MÈDIQUES I DE LA SALUT DE CATALUNYA I BALEARS
Proporcionar als residents en últim any de l’especialitat d’Oncologia Radioteràpica o als especialistes en Oncologia Radioteràpica, l’oportunitat d’ampliar o d’actualitzar la seva formació tant clínica com de recerca a un o més centres de l’estranger.
 
Premis
Termini exhaurit
HOSP. UNIV. VALDECILLA - HOSPITAL UNIVERSITARIO MARQUES DE VALDECILLA
Fomentar la participació dels professionals d'infermeria en l'elaboració i desenvolupament de projectes d'investigació que versen sobre la pràctica infermera, en qualsevol de les seves vessants: assistencial, docent o de gestió.
 
Termini exhaurit
UNIVERSITAT DE VALÈNCIA / AJUNTAMENT D'ALZIRA
Estimular la creació i difusió d'obres que posin a l'abast del públic en general, i dels estudiants preuniversitaris en particular, els avenços científics i tecnològics i també la divulgació d'aspectes interessants de les diferents branques del saber.
 
Recursos Humans
Termini exhaurit
FUNDACIÓN TATIANA PÉREZ DE GUZMÁN EL BUENO
Convocar 3 beques/contractes predoctorals en Neurociència per a espanyols que vagin a realitzar la seva tesi doctoral en un Programa de doctorat acreditat oficialment a Espanya.
L'objectiu de les beques/contractes és la realització de la tesis doctoral en Neurociència enfocada a la comprensió del sistema nerviós humà i de les malalties que l'afecten.
 
Termini exhaurit
FUNDACIÓ ACADÈMIA DE CIÈNCIES MÈDIQUES I DE LA SALUT DE CATALUNYA I BALEARS
La beca "Agustí Pumarola" es constitueïx com una ajuda als professionals interessats en la Microbiología Clínica i en les Malalties Infeccioses, que vulguin realitzar un projecte d'investigació pre-doctoral en un centre espanyol.
 
 
 
Informació últil
 
 No hi ha novetats
 
 
Banner-convocatories-tancament-02
Projectes
Termini exhaurit
MSCBS - MINISTERIO DE SANIDAD
Ajuts econòmics pel desenvolupament de projectes d’investigació sobre drogodependències realitzats per entitats públiques o privades sense afany de lucre.
 
Termini exhaurit
COMISSIÓ EUROPEA
The Directorate-General for Health and Consumers is responsible for the implementation of European Union laws on the safety of food and other products, on consumers' rights and on the protection of people's health.
 
Termini exhaurit
AECC Catalunya - ASSOCIACIÓ ESPANYOLA CONTRA EL CÁNCER DE CATALUNYA
La junta de Barcelona de l’AECC convoca adjudes destinades al finançament de 5 projectes d’investigació en oncologia. Es valoraran especialment els treballs de recerca clínica, translacional i en psicooncologia, així com de previsible repercussió social.
Aquestes ajudes estan destinades a professionals i investigadors d'àrees relacionades amb l'oncologia per desenvolupar un projecte de recerca en un centre pertanyent a Barcelona i les seves comarques amb la finalitat de potenciar la investigació oncològica en els equips d'investigació emergents.
 
 
Termini exhaurit
DEPARTMENT OF DEFENSE
The Breast Cancer Research Program (BCRP) challenges the scientific community to design research that will address the urgency of ending breast cancer. Specifically, the BCRP seeks to accelerate high-impact research with clinical relevance, encourage innovation and stimulate creativity,and facilitate productive collaborations.
 
Premis
Termini exhaurit
American Society for Clinical Investigation
The American Society for Clinical Investigation (ASCI) established in 1908, is one of the nation's oldest and most respected medical honor societies. The ASCI is dedicated to the advancement of research that extends the understanding and improves the treatment of human diseases, and its members are committed to mentoring future generations of physician-scientists.

The Harrington Discovery Institute at University Hospitals Case Medical Center, part of a national initiative unveiled in February 2012 called the Harrington Project, is a nonprofit medical institute dedicated to physician-scientists, enabling them to transform breakthrough insights into novel therapies that enhance patient care. The Harrington Project is fueled by $250 million in donations and other funding, including $50 million from the Harrington Family.
 
Recursos Humans
Termini exhaurit
EMBO - THE EUROPEAN MOLECULAR BIOLOGY ORGANIZATION
Promoure la recerca internacional sobre Biologia Molecular i en especial la mobilitat dels investigadors que vulguin treballar a un centre d'un altre país.
 
 
 
 
Articles
 
Maitre L, Fthenou E, Athersuch TJ, Coen M, Toledano MB, Holmes E, Kogevinas M, Chatzi L*, Keun HC*. Urinary metabolic profiles in early pregnancy are associated with preterm birth and fetal growth restriction in the Rhea mother-child cohort study. BMC med 2014; 12: 110.
 
Wang Z, Zhu B, Zhang M, Parikh H, Jia J, Chung CC, Sampson JN, Hoskins JW, Hutchinson A, Burdette L, Ibrahim A, Hautman C, Raj PS, Abnet CC, Adjei AA, Ahlbom A, Albanes D, Allen NE, Ambrosone CB, Aldrich MC, Amiano P, Amos CI, Andersson U, Andriole Jr G, Andrulis IL, Arici C, Arslan AA, Austin MA, Baris D, Barkauskas DA, Bassig BA, Beane Freeman LE, Berg CD, Berndt SI, Bertazzi P, Biritwum RB, Black A, Blot WJ, Boeing H, Boffetta P, Bolton K, Boutron-Ruault MC, Bracci PM, Brennan P, Brinton LA, Brotzman M, Bueno de Mesquita B, Buring JE, Butler MA, Cai Q, Cancel-Tassin G, Canzian F, Cao G, Caporaso NE, Carrato A, Carreon T, Carta A, Chang GC, Chang IS, Chang-Claude J, Che X, Chen CJ, Chen CY, Chen CH, Chen C, Chen KY, Chen YM, Chokkalingam AP, Chu LW, Clavel-Chapelon F, Colditz GA, Colt JS, Conti D, Cook MB, Cortessis VK, Crawford ED, Cussenot O, Davis FG, de Vivo I, Deng X, Ding T, Dinney CPN, Di Stefano AL, Diver WR, Duell EJ, Elena JW, Fan JH, Feigelson HS, Feychting M, Figueroa JD, Flanagan AM, Fraumeni Jr JF, Freedman ND, Fridley BL, Fuchs CS, Gago-Domínguez M, Gallinger S, Gao YT, Gapstur SM, García-Closas M, García-Closas R, Gastier-Foster JM, Gaziano JM, Gerhard DS, Giffen CA, Giles GG, Gillanders EM, Giovannucci EL, Goggins M, Gokgoz N, Goldstein AM, González C, Gorlick RG, Greene MH, Gross MD, Grossman HB, Grubb III R, Gu J, Guan P, Haiman CA, Hallmans G, Hankinson SE, Harris CC, Hartge P, Hattinger C, Hayes RB, He Q, Helman L, Henderson BE, Henriksson R, Hoffman-Bolton J, Hohensee C, Holly EA, Hong YC, Hoover RN, Hosgood III HD, Hsiao CF, Hsing AW, Hsiung CA, Hu N, Hu W, Hu Z, Huang MS, Hunter DJ, Inskip PD, Ito H, Jacobs EJ, Jacobs KB, Jenab M, Ji BT, Johansen C, Johansson M, Johnson A, Kaaks R, Kamat AM, Kamimeni A, Karagas MR, Khanna C, Khaw KT, Kim C, Kim IS, Kim YH, Kim YC, Kim YT, Kang CH, Jung YJ, Kitahara CM, Klein AP, Klein R, Kogevinas M, Koh WP, Kohno T, Kolonel LN, Kooperberg C, Kratz CP, Krogh V, Kunitoh H, Kurtz RC, Kurucu N, Lan Q, Lathrop M, Lau CC, Lecanda F, Lee KM, Lee MP, Le Marchand L, Lerner SP, Li D, Liao L, Wim WY, Lin D, Lin J, Lindstrom S, Linet MS, Lissowska J, Liu J, Ljungberg B, Lloreta J, Lu D, Ma J, Malats N, Mannisto S, Marina N, Mastrangelo G, Matsuo K, McGlynn KA, McKean-Cowdin R, McNeill LH, McWilliams RR, Melin BS, Meltzer PS, Mensah JE, Miao X, Michaud DS, Mondul AM, Moore LE, Muir K, Niwa S, Olson SH, Orr N, Panico S, Park JY, Patel AV, Patiño-García A, Pavanello S, Peeters PH, Peplonska B, Peters U, Petersen G, Picci P, Pike MC, Porru S, Prescott J, Pu X, Purdue MP, Qiao YL, Rajaraman P, Riboli E, Risch HA, Rodabough RJ, Rothman N, Ruder AM, Ryu JS, Sanson M, Schned A, Schumacher FR, Schwartz AG, Schwartz KL, Schwenn M, Scotlandi K, Seow A, Serra C, Serra M, Sesso HD, Severi G, Shen H, Shen M, Shete S, Shiraishi K, Shu XO, Siddiq A, Sierrasesúmaga L, Sierri S, Sihoe AD, Silverman D, Simón M, Southey MC, Spector L, Spitz MR, Stampfer M, Stattin P, Stern MC, Stevens VL, Stolzenberg-Solomon RZ, Stram D, Strom SS, Su WC, Sund M, Sung SW, Swerdlow A, Tan W, Tanaka H, Tang W, Tang ZZ, Tardón A, Tay E, Taylor PR, Tettey Y, Thomas DM, Tirabosco R, Tjoneeland A, Tobias GS, Toro JR, Travis RC, Trichopoulos D, Troisi R, Truelove A, Tsai YH, Tucker M, Tumino R, Van Den Berg D, Van Den Eeden SK, Vermeulen R, Vineis P, Visvanathan K, Vogel U, Wang C, Wang C, Wang J, Wang SS, Weiderpass E, Weinstein SJ, Wentzensen N, Wheeler W, White E, Wiencke JK, Wolk A, Wolpin BM, Wong MP, Wrensch M, Wu C, Wu T, Wu X, Wu YL, Wunder JS, Xiang YB, Xu J, Yang HP, Yang PC, Yatabe Y, Ye Y, Yeboah ED, Yin Z, Ying C, Yu CJ, Yu K, Yuan JM, Zanetti KA, Zeleniuch-Jacquotte A, Zheng W, Zhou B, Mirabello L, Savage SA, Kraft P, Chanock SJ, Yeager M, Landi MT, Shi J, Chatterjee N, Amundadottir L*. Imputation and subset based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33. Hum Mol Genet 2014; 23(24): 6616-6633.
 
Segura-Puimedon M, Sahún I, Velot E, Dubus P, Borralleras C, Rodrigues AJ, Valero MC, Valverde O, Sousa N, Herault Y, Dierssen M, Pérez-Jurado L, Campuzano V*. Heterozygous deletion of the Williams-Beuren syndrome critical interval in mice recapitulates most features of the human disorder. Hum Mol Genet 2014; 23(24): 6481-6494.
 
Cañadas I, Taus A, González I, Villanueva X, Gimeno J, Pijuan L, Domine M, Sánchez-Font A, Vollmer I, Menéndez S, Arpí O, Mojal S, Rojo F, Rovira A, Albanell J, Arriola E*. High circulating hepatocyte growth factor levels associate with epithelial to mesenchymal transition and poor outcome in small cell lung cancer patients. Oncotarget 2014; 5(14): 5246-5256.
 
Conde-Estevez D*, Grau S. Comment on: Glycopeptide use is associated with increased mortality in Enterococcus faecalis bacteraemia. J Antimicrob Chemother 2014; 69(11): 3165-3166.
 
Rizzoli R*, Branco J, Brandi ML, Boonen S, Bruyère O, Cacoub P, Cooper C, Díez-Pérez A, Duder J, Fielding RA, Harvey NC, Hiligsmann M, Kanis JA, Petermans J, Ringe JD, Tsouderos Y, Weinman J, Reginster JY. Management of osteoporosis of the oldest old. Osteoporosis Int 2014; 25(11): 2507-2529.
 
Abramowicz D*, Cochat P, Claas F, Heemann U, Pascual J, Dudley C, Harden P, Hourmant M, Maggiore U, Salvadori M, Spasovski G, Squifflet JP, Steiger J, Torres A, Viklicky O, Zeier M, Vanholder R, Van Biesen W, Nagler E. European Renal Best Practice Guideline on kidney donor and recipient evaluation and perioperative care. Nephrol Dial Transplant 2015; 30(11): 1790-1797.
 
Argudo N, Pereira JA*, Sancho JJ, Membrilla E, Pons-Fragero MJ, Grande L. Prophylactic synthetic mesh can be safely used to close emergency laparotomies, even in peritonitis. Surgery 2014; 156(5): 1238-1244.
 
Roquer González J*, Rodríguez Campello A, Cuadrado E, Giralt E, Jiménez Conde J, Dégano IR, Ois A. Ischemic stroke in prediabetic patients. J Neurol 2014; 261(10): 1866-1870.
 
Puig-Vilanova E, Ausin P, Martínez-Llorens JM, Gea J, Barreiro E*. Do epigenetic events take place in the vastus lateralis of patients with mild chronic obstructive pulmonary disease?. PLoS ONE 2014; 9(7): e102296.
 
Sampson VB, David JM, Puig I, Patil PU, García de Herreros A, Thomas GV, Rajasekaran AK*. Wilms' tumor protein induces an epithelial-mesenchymal hybrid differentiation state in clear cell renal cell carcinoma. PLoS ONE 2014; 9(7): e102041.
 
McNicholl AG, Forné M, Barrio J, De la Coba C, González B, Rivera R, Esteve M, Fernández-Bañares F, Madrigal B, Gras-Miralles B, Pérez-Aisa A, Viver JM, Bory F, Rosinach M, Loras C, Esteban C, Santolaria S, Gomollón F, Valle J, Gisbert JP, On behalf of the Helicobacter pylori Study Group of the Asociación Española de Gastroenterología (AEG). Accuracy of GastroPanel for the diagnosis of atrophic gastritis. Eur J Gastroenterol Hepatol 2014; 26(9): 941-948.
 
Geva R, Vecchione L, Kalogeras KT, Jensen BV, Lenz HJ, Yoshino T, Páez D, Montagut C, Souglakos J, Cappuzzo F, Cervantes A, Frattini M, Fountzilas G, Johansen JS, Hogdall EV, Zhang W, Yang D, Yamazaki K, Nishina T, Papamichael D, Vincenzi B, Macarulla T, Loupakis F, De Schutter J, Spindler KL, Pfeiffer P, Ciardiello F, Piessevaux H, Tejpar S*. FCGR polymorphisms and cetuximab efficacy in chemorefractory metastatic colorectal cancer: an international consortium study. Gut 2015; 64(6): 921-928.
 
González Svatetz CA*, Goday A. Obesidad y cáncer: «las amistades peligrosas». Med Clin (Barc) 2015; 145(1): 24-30.
 
 
Prats E, Domínguez E, Rosado S, Pailhez G, Bulbena A, Fullana MA*. Effectiveness of cognitive-behavioral group therapy for panic disorder in a specialized unit. Actas Esp Psiquiatr 2014; 42(4): 176-184.
 
Pedro-Botet J*, Flores JA, Mostaza JM, Pintó X, de la Cruz JJ, Banegas JR, en nombre del grupo de investigadores EDICONDIS-ULISEA. Dislipemia aterogénica: prevalencia y control en las unidades de lípidos. Rev Clin Esp 2014; 214(9): 491-498.
 
López MA*, Duran X, Alonso J, Martínez-Martínez JM, Espallargues M, Benavides FG. Estimación de la carga de enfermedad por incapacidad laboral permanente en España durante el período 2009-2012. Rev Esp Salud Pública 2014; 88(3): 349-358.
 
 
Tel: 93 316 04 00
Doctor Aiguader, 88
08003 Barcelona
Seguiu-nos a:
Twitter
Youtube
En compliment de la Llei 34/2002, de Serveis de la Societat de la Informació i de Comerç Electrònic, aquest correu li hem enviat a partir de les dades de contacte que vostè ens ha facilitat. Si vostè no desitja rebre més comunicats, pot donar-se de baixa dirigint-se per escrit al Servei de Recursos Humans-IMIM (RRHHconfidencialitat@imim.es) tot indicant la paraula “baixa base de dades” a l’assumpte.
Li recordem que podrà exercir els drets d’accés, rectificació, cancel·lació i oposició dirigint-se per escrit al Servei de Recursos Humans-IMIM (RRHHconfidencialitat@imim.es).